Daily Roundup

RMD.ASX BBN.ASX QBE.ASX EQU.ASX MXO.ASX

Resmed wrapped up its fiscal year 2026 with some strategic moves aimed at sharpening its focus. The company acquired Noctrix Health to bolster its sleep health offerings while simultaneously offloading its MatrixCare business for $490 million. That divestiture allows the company to concentrate on what it does best: digital health and cloud-connected medical devices. The company had 144.3 million shares outstanding as of mid-August, and expects to close the MatrixCare sale in the first quarter of fiscal 2027. Management sees continued momentum ahead in sleep, breathing, and connected home-based healthcare.

Baby Bunting is firing on all cylinders heading into the new financial year. The retailer posted record sales of $556 million, up 6.5% year-over-year, while pro forma net profit after tax surged 33.9% to $16.1 million. Comparable store sales grew 3.5%, and the company's gross margin expanded to 41.2%—a meaningful improvement that reflects a strategic shift toward higher-margin soft goods and exclusive brands. New Zealand proved particularly strong, with comparable store sales jumping 17%. The company's Store of the Future refurbishment program is delivering results, with refurbished locations seeing an average 18% sales lift. Looking ahead, Baby Bunting is guiding for FY27 pro forma net profit between $19 million and $21 million, with total sales projected between $585 million and $600 million. The company is targeting a gross margin of 42% and plans capital expenditure of $33 million to $37 million.

QBE Insurance Group delivered a solid first half, demonstrating the strength of its disciplined underwriting approach. Gross written premium grew 6% on a constant currency basis to $15.1 billion, while adjusted net profit after tax climbed 4% to $1.033 billion. The company's return on equity hit 17.7%, comfortably exceeding its medium-term outlook of 15% or better. The combined operating ratio held steady at 92.8%, right on track for the full-year target of around 92.5%. QBE also increased its interim dividend per share by 6% to 33 cents, maintaining a payout ratio of approximately 30%. The company's capital position remains robust, with a pro forma PCA multiple of 1.78x after the dividend payment. QBE completed a A$450 million on-market share buyback, underscoring confidence in its balance sheet strength.

Equus Energy reached a major milestone with a binding conditional Gas Sales Agreement with Alcoa of Australia. Under the 10-year deal, Equus will supply approximately 50 terajoules per day—representing roughly 5% of Western Australia's domestic gas market. The agreement also unlocks up to US$30 million in project funding to help advance the Equus Gas Project through Pre-FEED, FEED, and toward a Final Investment Decision. With Alcoa now locked in as its foundation domestic gas customer, Equus is well-positioned to move forward on commercializing the project and strengthening energy security for the region.

Motio Ltd reported mixed results for fiscal 2026, though profitability tells the real story. While revenue from continuing operations dipped 2% to $9.2 million, the company delivered a stunning 1,796% surge in profit after tax to $2.2 million. Cash EBITDA jumped 31% to $2.5 million, signaling improving operational efficiency. The company is holding off on dividends for now, but net tangible assets per security nearly doubled from 1.02 cents to 1.95 cents, reflecting the underlying strength of the balance sheet.